Latvian Healthcare Professionals’ Self-Reported Knowledge, Attitudes, and Behaviors Related to Pregnancy Prevention Program Materials for Valproate-Containing Medicines
Background: Valproates are recognized for their significant teratogenic risks, which can lead to physical defects and developmental disorders when used during pregnancy. To mitigate these risks, the Pregnancy Prevention Program (PPP) was developed by European regulators for patients and healthcare p...
Saved in:
| Main Authors: | Milana Špoģe, Mirdza Kursīte, Elita Poplavska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Pharmacy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2226-4787/12/6/182 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Unveiling Thrombocytopenia Trends In Pediatric Epilepsy: The Valproate Connection
by: Kiran Nayab, et al.
Published: (2025-01-01) -
Case report and literature review of refractory hypoalbuminemic ascites caused by so-dium valproate
by: Hui-Min YANG, et al.
Published: (2021-10-01) -
The Impact of Sitagliptin on Sodium Valproate-Induced Autism in a Mouse Model
by: Ahmed Sudan Abbas, et al.
Published: (2024-09-01) -
Association of valproate use and hippocampal atrophy in idiopathic generalized epilepsy
by: Xiang Huang, et al.
Published: (2025-01-01) -
Anxiolytic and sedative effects of sodium valproate with different experimental paradigms in male and female rats
by: María de losÁngeles Cintado, et al.
Published: (2024-12-01)